Sort
21,453 grants matching “tuberculosis”
Biochemistry of Energy-Dependent (Intracellular) Protein Degradation
$655,812Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Predictors of treatment toxicity, failure, and relapse in HIV-related tuberculosis
$655,701Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2016 · AI
Sepsis Characterization in Kilimanjaro
$655,648Matthew P Rubach · Duke University · R01 · FY2023 · AI
A TB Vaccine for AIDS Patients
$655,618Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2008 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$655,601Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2021 · AI
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
$655,464Michael David Hughes · Harvard School Of Public Health · UM1 · FY2020 · AI
Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS
$655,412Johns Hopkins University · R01 · FY2005 · AI
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children
$655,395Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2020 · HL
SAIA-TB: Using the Systems Analysis and Improvement Approach (SAIA) to prevent TB in rural South Africa
$655,369Brittney Jayne Van De Water · Boston College · R01 · FY2023 · NR
Targets in M. Tuberculosis:Stress Resistance &Repair
$655,344Weill Medical College Of Cornell Univ · R01 · FY2005 · AI
Strategies for tuberculosis control in prisons
$655,282Jason Randolph Andrews · Stanford University · R01 · FY2021 · AI
Targeting Hsp90 in cryptococcal fungal pathogenesis
$655,235Leah Elizabeth Cowen · University Of Toronto · R01 · FY2023 · AI
Exploring the metabolism of non-replicating and drug-resistant TB
$655,103Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$655,091Gillian L Beamer · Tufts University Boston · R01 · FY2020 · HL
Trial of Vitamin D Supplementation to Prevent TB Infection in Schoolchildren
$654,963Ganmaa Davaasambuu · Harvard School Of Public Health · R01 · FY2016 · HL
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$654,921Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
$654,844David R Boulware · University Of Minnesota · R01 · FY2019 · NS
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
$654,715David Crich · University Of Georgia · R01 · FY2023 · AI
Memory, Phenotype, and Function of TB-reactive Human MR1 Restricted T cells
$654,713David M. Lewinsohn · Oregon Health & Science University · R01 · FY2019 · AI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi
$654,538Philip C Hopewell · University Of California, San Francisco · R01 · FY2013 · AI
Defining how the spectrum of latency affects reactivation of TB
$654,521Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL
Longitudinal Study of HIV and Aging in Brazil
$654,308Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2024 · AG
Continuity of Care for Drug-Addicted Offenders in RI
$654,037Rhode Island Hospital · U01 · FY2005 · DA
Patient reported outcomes in patients with nontuberculous mycobacterial pulmonary disease
$653,961Emily M. Henkle · Oregon Health & Science University · R01 · FY2024 · HL
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$653,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2023 · AI